CEAS: cis-regulatory element annotation systemSHIN, Hyunjin; TAO LIU; MANRAI, Arjun K et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 19, pp 2605-2606, issn 1367-4803, 2 p.Article

Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancerHIGASHI, H; HIRABAYASHI, Y; FUKUI, Y et al.Cancer research (Baltimore). 1985, Vol 45, Num 8, pp 3796-3802, issn 0008-5472Article

Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in CosmcTONGZHONG JU; LANNEAU, Grainger S; LASZIK, Zoltan et al.Cancer research (Baltimore). 2008, Vol 68, Num 6, pp 1636-1646, issn 0008-5472, 11 p.Article

Remarques, critiques sur la signification des marqueurs tumoraux = About the signification of tumoral markersSTEFFEN, A.Lyon Méditerranée médical. Médecine du sud-est. 1989, Vol 25, Num 5-6, issn 0766-5466, 12329-12334 [4 p.]Article

A mutant chaperone converts a wild-type protein into a tumor-specific antigenSCHIETINGER, Andrea; PHILIP, Mary; YOSHIDA, Barbara A et al.Science (Washington, D.C.). 2006, Vol 314, Num 5797, pp 304-308, issn 0036-8075, 5 p.Article

Les vaccins thérapeutiques : L'arsenal biotech contre les cancers = Therapeutic vaccinesMOINGEON, Philippe.Biofutur (Puteaux). 2001, Num 212, pp 54-57, issn 0294-3506Article

Clinical experience with CA-50 in the serum of carcinoma patientsHABIB, N. A; HERSHMAN, M. J; KELLY, S. B et al.European journal of surgical oncology. 1989, Vol 15, Num 4, pp 361-366, issn 0748-7983Article

Tumour marker immunoreactivity in adenocarcinomaELLIS, I. O; HITCHCOCK, A.Journal of clinical pathology. 1988, Vol 41, Num 10, pp 1064-1067, issn 0021-9746Article

Melanoma-associated antigens: prospects for clinical useLEJEUNE, F. J; LIBERT, A.European journal of cancer & clinical oncology. 1985, Vol 21, Num 12, pp 1433-1438, issn 0277-5379Article

Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigensYOUNG, D. A; PROUT, G. R. JR; CHI-WEI LIN et al.Cancer research (Baltimore). 1985, Vol 45, Num 9, pp 4439-4446, issn 0008-5472Article

Cancer Mucosa Antigens as a Novel Immunotherapeutic Class of Tumor-associated AntigenSNOOK, A. E; EISENLOHR, L. C; ROTHSTEIN, J. L et al.Clinical pharmacology and therapeutics. 2007, Vol 82, Num 6, pp 734-739, issn 0009-9236, 6 p.Article

The universal character of the tumor-associated antigen survivinHALD ANDERSEN, Mads; MARIE SVANE, Inge; BECKER, Jurgen C et al.Clinical cancer research. 2007, Vol 13, Num 20, pp 5991-5994, issn 1078-0432, 4 p.Article

Haemangiopericytomas : the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA)àYU, C. C.-W; HALL, P. A; FLETCHER, C. D. M et al.Histopathology. 1991, Vol 19, Num 1, pp 29-33, issn 0309-0167Article

Serum TAG 72 levels in different human carcinomasCORREALE, M; ABBATE, I; GARGANO, G et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1991, Vol 18, Num 1, pp 101-103, issn 0883-2897Conference Paper

The nature of the monoclonal antibodies derived from immunogenic membrane antigen of human colon carcinoma originARLEN, M; TSANG, A. K.Journal of tumor marker oncology. 1990, Vol 5, Num 4, pp 313-319, issn 0886-3849Article

U.S.-Japan cooperative cancer research program conference : fundamental and clinical aspects of pancreatic cancerSCARPELLI, D. G; KONISHI, Y.Cancer research (Baltimore). 1990, Vol 50, Num 3, pp 766-769, issn 0008-5472Conference Paper

Valeur et limites du CA 19-9 en cancérologie = Value and limitations of CA 19-9 in cancerologySURIEZ, D; LAFITTE, J. J; VINDIMIAN, M et al.La Revue de médecine interne (Paris). 1985, Vol 4, Num 4, pp 411-417, issn 0248-8663Article

Multiple epitopes on a human breast-carcinoma-associated antigenPRICE, M. R; EDWARDS, S; OWAINATI, A et al.International journal of cancer. 1985, Vol 36, Num 5, pp 567-574, issn 0020-7136Article

Expression of normal and tumor-associated antigens in human breast carcinomaSAWTELL, N. M; DIPERSIO, L; MICHAEL, J. G et al.Laboratory investigation. 1984, Vol 51, Num 2, pp 225-232, issn 0023-6837Article

Cranking the immunologic engine with chemotherapy : Using context to drive tumor antigen cross-presentation towards useful antitumor immunityVAN DER MOST, Robbert G; CURRIE, Andrew; ROBINSON, Bruce W. S et al.Cancer research (Baltimore). 2006, Vol 66, Num 2, pp 601-604, issn 0008-5472, 4 p.Article

A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular responseMONZAVI-KARBASSI, Behjatolah; PING LUO; JOUSHEGHANY, Fariba et al.Cancer research (Baltimore). 2004, Vol 64, Num 6, pp 2162-2166, issn 0008-5472, 5 p.Article

Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant diseaseFILELLA, X; MOLINA, R; JO, J et al.Bulletin du cancer. 1992, Vol 79, Num 3, pp 271-277, issn 0007-4551Article

Methods in laboratory investigation : combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft modelsDEPALATIS, L. R; JOHNSON, K. A; KAPLAN, D. A et al.Laboratory investigation. 1991, Vol 65, Num 1, pp 111-120, issn 0023-6837Article

Purification and characterization of a pancreas cancer-related antigenFURUKAWA, J; SHIMANO, T; INAJI, H et al.Clinica chimica acta. 1987, Vol 168, Num 2, pp 219-230, issn 0009-8981Article

Augmenting Antitumor T-Cell Responses to Mimotope Vaccination by Boosting with Native Tumor AntigensBUHRMAN, Jonathan D; JORDAN, Kimberly R; U'REN, Lance et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 1, pp 74-85, issn 0008-5472, 12 p.Article